Artificial intelligence and medical technology company Echo IQ (ASX:EIQ) secured commitments to raise approximately AU$7.1 million through the issue of 47.4 million new shares at AU$0.15 each, according to a Friday filing with the Australian Securities Exchange.
Proceeds will be utilized for commercialization, product development, and extending the company's cash runway through the Food and Drug Administration approval for its aortic stenosis and heart failure solutions, the filing said.
Shares rose more than 6% in midday trading.
Price (AUD): $0.17, Change: $+0.010, Percent Change: +6.25%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.